Log in
Enquire now
‌

US Patent 11534414 Bupropion as a modulator of drug activity

OverviewStructured DataIssuesContributors

Contents

TimelineTable: Further ResourcesReferences
Is a
Patent
Patent
1

Patent attributes

Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
1
Patent Number
115344141
Patent Inventor Names
Herriot Tabuteau1
Date of Patent
December 27, 2022
1
Patent Application Number
175266761
Date Filed
November 15, 2021
1
Patent Citations
‌
US Patent 10786469 Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
‌
US Patent 11213521 Bupropion as a modulator of drug activity
1
‌
US Patent 11229640 Combination of dextromethorphan and bupropion for treating depression
‌
US Patent 11234946 Bupropion as a modulator of drug activity
1
‌
US Patent 11253491 Bupropion as a modulator of drug activity
1
‌
US Patent 11253492 Bupropion as a modulator of drug activity
1
‌
US Patent 11273133 Bupropion as a modulator of drug activity
‌
US Patent 11273134 Bupropion as a modulator of drug activity
...
Patent Citations Received
‌
US Patent 11617747 Bupropion as a modulator of drug activity
41
‌
US Patent 11628149 Bupropion as a modulator of drug activity
42
‌
US Patent 11752144 Compounds and combinations thereof for treating neurological and psychiatric conditions
‌
US Patent 11779579 Bupropion as a modulator of drug activity
‌
US Patent 11883373 Treatment of depression in certain patient populations
43
‌
US Patent 11925636 Bupropion dosage forms with reduced food and alcohol dosing effects
44
‌
US Patent 11969421 Bupropion as a modulator of drug activity
45
‌
US Patent 11986444 Treatment of poor metabolizers of dextromethorphan with a combination of bupropion and dextromethorphan
46
...
Patent Primary Examiner
‌
Yevgeny Valenrod
1
CPC Code
‌
A61K 31/485
1
‌
A61P 25/24
1
‌
A61K 9/0053
1
‌
A61K 31/137
1

Dosage forms, drug delivery systems, and methods related to sustained release of dextromethorphan or improved therapeutic effects are disclosed. Typically, bupropion or a related compound is orally administered to a human being to be treated with, or being treated with, dextromethorphan.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11534414 Bupropion as a modulator of drug activity

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us